Fulcrum Therapeutics FULC
NASDAQ FULC
$3.70 +0.00 (+0.14%)
As of: Oct 22, 2026 · 11:53 AM EDT

Fulcrum Therapeutics (FULC) Receivables - Net (2020)

Updated

Fulcrum Therapeutics' Receivables - Net was $2,000 in Q4 2020.

Analysis

Fulcrum Therapeutics (FULC) Receivables - Net (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,170.86 Bn 1,139.45 Bn 19.71 Bn
2 Johnson & Johnson 639.81 Bn 558.34 Bn 17.26 Bn
3 AbbVie 501.68 Bn 474.79 Bn 12.70 Bn
4 Merck 374.79 Bn 329.16 Bn 12.21 Bn
5 Novartis Ag 302.69 Bn 266.68 Bn 11.24 Bn
6 Astrazeneca 268.27 Bn 241.96 Bn 12.86 Bn
7 Amgen 242.43 Bn 197.83 Bn 7.24 Bn
8 Gilead Sciences 193.38 Bn 167.58 Bn 6.22 Bn
9 Pfizer 172.45 Bn 119.10 Bn 10.94 Bn
10 Fulcrum Therapeutics 282.18 Mn -61.16 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 2,000.00
API Access

Fulcrum Therapeutics Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=FULC&period=max&api_key=YOUR_API_KEY